Neuromyelitis optica spectrum disordersMaría Sepúlveda, Inmaculada Puertas, Thaís Armangué et al.|Neurology Neuroimmunology & Neuroinflammation|2016Cited by 153
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimatesMaría Sepúlveda, Albert Saiz, Marta Aldea et al.|Multiple Sclerosis Journal|2017Cited by 100
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MSCristina Ramo‐Tello, Laia Grau‐López, Mar Tintoré et al.|Multiple Sclerosis Journal|2013Cited by 75
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data NetworkJohannes Lorscheider, Jan Hillert, Anna Glaser et al.|Journal of Neurology Neurosurgery & Psychiatry|2024Cited by 4